Webinar: Chemical Exposure Profiling of Alzheimer's Patients Register Now

Appliction Note

Exposomics Measuring Chemical Drivers of Human Disease

Panome Bio’s Exposomics platform enables comprehensive measurement of chemical exposures that drive human disease. Using integrated discovery (32,000+ compounds) and targeted profiling (235 priority chemicals), we detect and quantify exogenous exposures at trace levels. Demonstrated in Alzheimer’s disease, our workflow reveals disease-associated environmental signatures with high sensitivity and confidence. Read the application note to learn more.

Exposomics Measuring Chemical Drivers of Human Disease

Download Now


Your privacy is important to us.
We’ll never share your information.

Skip to content